Table 1 (abstract PReS24-ABS-1180).
See description
| Parameter, Me (25%;75) | JIA-associated uveitis, n=111 (%) |
CIA, n= 39 (%) |
p |
|---|---|---|---|
| Type of uveitis, n (%) | |||
| - Anterior* | 82 (73) | 19 (49) | 0.032 |
| - Parsplanitis | 4 (4) | 2 (5) | |
| - Posterior | 4 (4) | 4 (10) | |
| - Panuveitis | 21 (19) | 14 (36) | |
| Time before methotrexate, years | 1.6 (0.1; 2.3) | 2.7 (0.4; 4.2) | 0.005 |
| Time before remission on methotrexate, years | 0.75 (0.17; 0.42) | 0.2 (0.1; 0.3) | 0.07 |
| Flares on methotrexate, n (%) | 27/58 (47) | 12/16 (75) | 0.044 |
| Time before flare, years | 1.0 (0.75; 1.7) | 1.2 (0.3; 1.4) | 0.3 |
| Time before biologics since uveitis onset, years | 2.7 (0.7; 4.0) | 4.0 (1.1; 6.2) | 0.03 |
| Time before remission on biologics, years | 0.3 (0.1; 0.6) | 0.2 (0.1; 0.3) | 0.080 |
| Flare on biologics, n (%) | 22/55 (40) | 11/24 (46) | 0.629 |
| Time before flare on biologics, years | 1.8 (1.0; 2.7) | 1.2 (0.3; 1.9) | 0.100 |